UBI PHARMA INC.
🇹🇼Taiwan
- Country
- 🇹🇼Taiwan
- Ownership
- Public
- Established
- 2014-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.ubi-pharma.com
Study to Compare the Safety and Efficacy of UB-851 and Eprex®
Phase 3
Completed
- Conditions
- Renal Anemia
- Interventions
- Biological: UB-851Biological: Eprex
- First Posted Date
- 2016-03-15
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- UBI Pharma Inc.
- Target Recruit Count
- 269
- Registration Number
- NCT02708914
© Copyright 2025. All Rights Reserved by MedPath